A detailed history of Tritonpoint Wealth, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 4,076 shares of LLY stock, worth $3.13 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
4,076
Previous 3,835 6.28%
Holding current value
$3.13 Million
Previous $3.47 Billion 3.03%
% of portfolio
0.33%
Previous 0.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$772.14 - $960.02 $186,085 - $231,364
241 Added 6.28%
4,076 $3.58 Billion
Q2 2024

Aug 12, 2024

BUY
$724.87 - $909.04 $23,920 - $29,998
33 Added 0.87%
3,835 $3.47 Billion
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $83,500 - $111,711
141 Added 3.85%
3,802 $2.07 Billion
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $1.92 Million - $2.27 Million
3,661 New
3,661 $2.13 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Tritonpoint Wealth, LLC Portfolio

Follow Tritonpoint Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tritonpoint Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tritonpoint Wealth, LLC with notifications on news.